John Aballi
Principal executive officer pay for John Aballi, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
EXAGEN INC. (XGN) FY2023–FY2025
Aligned: paid up as stock roseCAP $775,325→$2,860,225 while $100 invested went $81.59→$253.33
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2023 | $931,950 | $775,325 |
| FY2024 | $1.2M | $2.0M |
| FY2025 | $1.4M | $2.9M |
The company's "$100 invested" index ran $81.59 at FY2023 → $253.33 by FY2025 — an annualized return of 76.2%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 76.2%/yr at XGN ( FY2023–FY2025). See the CEO track-record ranking for context.